![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Pharmaceutical Chemistry (K.I.) and Center for Drug Research (M.F.), Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia (P.I.M., J.O.M.); and Department of Biotechnology, Toyama Prefectural University, Toyama, Japan (S.-i.I.)
The glucuronidation of 17β-estradiol (β-estradiol) and 17
-estradiol (epiestradiol) was studied to elucidate how the orientation of the 17-OH group affects conjugation at the 3-OH or the 17-OH of either diastereomer. Recombinant human UDP-glucuronosyltransferases (UGTs) UGT1A1, UGT1A3, UGT1A7, UGT1A8, and UGT1A10 conjugated one or both diastereomers, mainly at the 3-OH. The activity of UGT1A4 was low and unique because it was directed merely toward the 17-OH of both aglycones. UGT1A10 exhibited particularly high estradiol glucuronidation activity, the rate and affinity of which were significantly higher in the case of β-estradiol than with epiestradiol. UGT1A9 did not catalyze estradiol glucuronidation, but UGT1A9-catalyzed scopoletin glucuronidation was competitively inhibited by β-estradiol. UGT2B4, UGT2B7, and UGT2B17 exclusively conjugated the estradiols at the 17-OH position in a highly stereoselective fashion. UGT2B4 was specific for epiestradiol; UGT2B7 glucuronidated both diastereomers, with high affinity for epiestradiol, whereas UGT2B17 only glucuronidated β-estradiol. UGT2B15 glucuronidated both estradiols at the 3-OH, with a strong preference for epiestradiol. Human UGT2A1 and UGT2A2 glucuronidated both diastereoisomers at both hydroxyl groups. Microsomal studies revealed that human liver mainly yielded epiestradiol 17-O-glucuronide, and human intestine primarily yielded β-estradiol 3-O-glucuronide, whereas rat liver preferentially formed β-estradiol 17-O-glucuronide. Of the three recombinant rat UGTs that were examined in this study, rUGT2B1 was specific for the 17-OH of β-estradiol, rUGT2B2 did not catalyze estradiol glucuronidation, whereas rUGT2B3 exhibited high activity toward the 17-OH in both diastereoisomers. The results show that although many UGTs can catalyze estradiol glucuronidation, there are marked differences in their kinetics, regioselectivity, and stereoselectivity.
This article has been cited by other articles:
![]() |
T. Sten, M. Kurkela, T. Kuuranne, A. Leinonen, and M. Finel UDP-Glucuronosyltransferases in Conjugation of 5{alpha}- and 5{beta}-Androstane Steroids Drug Metab. Dispos., November 1, 2009; 37(11): 2221 - 2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hu and P. I. Mackenzie Estrogen Receptor {alpha}, Fos-Related Antigen-2, and c-Jun Coordinately Regulate Human UDP Glucuronosyltransferase 2B15 and 2B17 Expression in Response to 17{beta}-Estradiol in MCF-7 Cells Mol. Pharmacol., August 1, 2009; 76(2): 425 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Itaaho, M. H. Court, P. Uutela, R. Kostiainen, A. Radominska-Pandya, and M. Finel Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10 Drug Metab. Dispos., April 1, 2009; 37(4): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sten, I. Bichlmaier, T. Kuuranne, A. Leinonen, J. Yli-Kauhaluoma, and M. Finel UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly Drug Metab. Dispos., February 1, 2009; 37(2): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Mackenzie, A. Rogers, J. Treloar, B. R. Jorgensen, J. O. Miners, and R. Meech Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase J. Biol. Chem., December 26, 2008; 283(52): 36205 - 36210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siissalo, H. Zhang, E. Stilgenbauer, A. M. Kaukonen, J. Hirvonen, and M. Finel The Expression of Most UDP-Glucuronosyltransferases (UGTs) Is Increased Significantly during Caco-2 Cell Differentiation, whereas UGT1A6 Is Highly Expressed Also in Undifferentiated Cells Drug Metab. Dispos., November 1, 2008; 36(11): 2331 - 2336. [Abstract] [Full Text] [PDF] |
||||